Phase III Trials of Eribulin Mesylate (E7389) in Extensively Pretreated Patients With Locally Recurrent or Metastatic Breast Cancer - Concepedia

Concepedia

Publication | Closed Access

Phase III Trials of Eribulin Mesylate (E7389) in Extensively Pretreated Patients With Locally Recurrent or Metastatic Breast Cancer

106

Citations

12

References

2010

Year

Chris Twelves, Javier Cortés, Linda T. Vahdat, J. Wanders, C Akerele, Peter A. Kaufman

Clinical Breast Cancer

Metastatic Breast CancerBreast OncologyPhase Iii TrialsMedicineLocally RecurrentPathologyBreast CancerCancer TreatmentOncologyRadiation Oncology

References

	Year	Citations

Page 1